Failure to Respond to Change in Condition and Clarify Psychotropic Orders
Summary
The facility failed to provide timely assessment and intervention for a resident who experienced a change in condition and was later hospitalized with sepsis, acute renal failure, acute hypoxic respiratory failure, and acute metabolic encephalopathy. The resident had diagnoses including COPD, heart failure, and diabetes, and the care plan directed staff to monitor and report symptoms such as fatigue, communication changes, and signs of discomfort or distress. Staff interviews and the record showed multiple observations of lethargy, altered mental status, reduced verbal response, difficulty swallowing, poor intake, and breathing concerns over the course of the day, but the progress notes did not document a change in status before the resident was sent to the hospital for altered mental status. The record and interviews showed that staff members observed the resident was not acting normally, including staring off, not talking much, appearing lethargic, having difficulty remaining upright, and eating and drinking very little. A CNA reported concerns to an LPN, and another nurse later noted the resident had a slight left-sided facial droop and was not talking right. The on-call provider’s note documented altered mental status, lethargy, possible facial droop, and that the resident had been symptomatic for about one day before transfer. The facility policy required prompt notification of the physician and resident representative for significant changes in condition, including deterioration in health or life-threatening conditions. The facility also failed to notify the provider to evaluate and review a 30-day psychotropic medication order for a new admission before the order expired. The resident had diagnoses including bipolar disorder, anxiety disorder, and memory impairment, and the care plan identified risk related to psychotropic drug use. Hospital discharge instructions included trazodone, quetiapine, and divalproex for 30 days, and the admission medication review specifically asked for clarification on whether the 30-day supply should be continued. The pharmacy medication regimen review also requested follow-up with the prescriber regarding the 30-day stop dates because the medications appeared to be maintenance medications, but the clarification was not documented, and the medications were stopped without tapering before being restarted later.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.